From the Desk of the CEO

A controlled substance prescription must be issued for a legitimate medical purpose and in the usual course of professional practice.

David B. Brushwood, BSPharm, JD

Pharmacist interventions can increase the percentage of patients with atherosclerotic cardiovascular disease (ASCVD) who are on appro-priate statin therapy and improve an organization’s quality metrics when conducted as part of a novel population health initiative, show new data by Haby and colleagues published in a recent issue of the Journal of the American Pharmacists Association.

Maria G. Tanzi, PharmD

In late September, the American College of Obstetricians and Gyne-cologists (ACOG) published an update to its position on OTC hor-monal contraceptives.

Loren Bonner

Last August, FDA approved pretomanid, a new antibiotic used in com-bination with bedaquiline (Sirturo—Janssen) and linezolid for treat-ment of patients with multidrug-resistant and extensively drug-resistant tuberculosis (TB).

Aina Abell

Longstanding lack of standardization for iron product labeling has led to frequent dispensing and administration errors.

Institute for Safe Medication Practices, Horsham, PA